Biosenic S Ais A Biotechnology Company Focused On Regenerative And Immune Medicineit Specializes In Developing Innovative Treatments For Autoimmuneinflammatoryand Degenerative Diseasesformed In October 2022 From The Merger Of Medsenic And Bone Therapeuticsbiosenic Combines Expertise In Immunomodulation And Cell Therapy To Meet Significant Medical Needs The Company Targets Two Main Areasmodulating Immune Responses To Treat Autoimmune Diseases And Restoring Function Through Regenerative Therapiesits Product Offerings Include The Arsenic Trioxideatoplatformfeaturing Arscimeda An Immunomodulatory Drug For Conditions Like Chronic Graft Versus Host Disease And Systemic Lupus Erythematosusbiosenic Also Develops Alloba An Allogeneic Cell Therapy For Bone Repaircurrently In Phase Iib Trials Biosenic Is Listed On Euronext Brussels And Operates Globallyfocusing On Advancing Its Clinical Assets Through Strategic Partnerships And Regulatory Achievementsthe Company Aims To Improve Patient Outcomes In Areas With High Unmet Medical Needs
